157 related articles for article (PubMed ID: 3390372)
1. Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB.
Aasland R; Lillehaug JR; Male R; Jøsendal O; Varhaug JE; Kleppe K
Br J Cancer; 1988 Apr; 57(4):358-63. PubMed ID: 3390372
[TBL] [Abstract][Full Text] [Related]
2. Oncogene profile of papillary thyroid carcinoma.
Sugg SL; Ezzat S; Zheng L; Freeman JL; Rosen IB; Asa SL
Surgery; 1999 Jan; 125(1):46-52. PubMed ID: 9889797
[TBL] [Abstract][Full Text] [Related]
3. Structure and expression of c-myc and c-fos proto-oncogenes in thyroid carcinomas.
Terrier P; Sheng ZM; Schlumberger M; Tubiana M; Caillou B; Travagli JP; Fragu P; Parmentier C; Riou G
Br J Cancer; 1988 Jan; 57(1):43-7. PubMed ID: 3348948
[TBL] [Abstract][Full Text] [Related]
4. Search for NTRK1 proto-oncogene rearrangements in human thyroid tumours originated after therapeutic radiation.
Bounacer A; Schlumberger M; Wicker R; Du-Villard JA; Caillou B; Sarasin A; Suárez HG
Br J Cancer; 2000 Jan; 82(2):308-14. PubMed ID: 10646882
[TBL] [Abstract][Full Text] [Related]
5. Oncogene expression in a medullary thyroid carcinoma.
Klimpfinger M; Ruhri C; Pütz B; Pfragner R; Wirnsberger G; Höfler H
Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 54(4):256-9. PubMed ID: 2895537
[TBL] [Abstract][Full Text] [Related]
6. Expression of c-erbB-2 protein in papillary thyroid carcinomas.
Haugen DR; Akslen LA; Varhaug JE; Lillehaug JR
Br J Cancer; 1992 Jun; 65(6):832-7. PubMed ID: 1352125
[TBL] [Abstract][Full Text] [Related]
7. Co-expression of the genes encoding transforming growth factor-alpha and its receptor in papillary carcinomas of the thyroid.
Aasland R; Akslen LA; Varhaug JE; Lillehaug JR
Int J Cancer; 1990 Sep; 46(3):382-7. PubMed ID: 1697567
[TBL] [Abstract][Full Text] [Related]
8. Structure and expression of nuclear oncogenes in multi-stage thyroid tumorigenesis.
Wyllie FS; Lemoine NR; Williams ED; Wynford-Thomas D
Br J Cancer; 1989 Oct; 60(4):561-5. PubMed ID: 2803926
[TBL] [Abstract][Full Text] [Related]
9. Application of fine-needle aspiration to the demonstration of ERBB2 and MYC expression by in situ hybridization in breast carcinoma.
Soini Y; Mannermaa A; Winqvist R; Kamel D; Poikonen K; Kiviniemi H; Pääkkö P
J Histochem Cytochem; 1994 Jun; 42(6):795-803. PubMed ID: 7910618
[TBL] [Abstract][Full Text] [Related]
10. Expression of c-erbB-2 oncoprotein in human thyroid tumours.
Utrilla JC; Martín-Lacave I; San Martín MV; Fernández-Santos JM; Galera-Davidson H
Histopathology; 1999 Jan; 34(1):60-5. PubMed ID: 9934586
[TBL] [Abstract][Full Text] [Related]
11. Co-existent anaplastic and well differentiated thyroid carcinomas: a nuclear DNA study.
Wallin G; Bäckdahl M; Tallroth-Ekman E; Lundell G; Auer G; Löwhagen T
Eur J Surg Oncol; 1989 Feb; 15(1):43-8. PubMed ID: 2465188
[TBL] [Abstract][Full Text] [Related]
12. Oncogenes and growth factors in thyroid carcinogenesis.
Frauman AG; Moses AC
Endocrinol Metab Clin North Am; 1990 Sep; 19(3):479-93. PubMed ID: 2175702
[TBL] [Abstract][Full Text] [Related]
13. Oncogene amplifications in early-stage human prostate carcinomas.
Latil A; Baron JC; Cussenot O; Fournier G; Boccon-Gibod L; Le Duc A; Lidereau R
Int J Cancer; 1994 Dec; 59(5):637-8. PubMed ID: 7960236
[TBL] [Abstract][Full Text] [Related]
14. c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma.
Tavassoli M; Quirke P; Farzaneh F; Lock NJ; Mayne LV; Kirkham N
Br J Cancer; 1989 Oct; 60(4):505-10. PubMed ID: 2572268
[TBL] [Abstract][Full Text] [Related]
15. Oncogene abnormalities in astrocytomas: EGF-R gene alone appears to be more frequently amplified and rearranged compared with other protooncogenes.
Burgart LJ; Robinson RA; Haddad SF; Moore SA
Mod Pathol; 1991 Mar; 4(2):183-6. PubMed ID: 1675468
[TBL] [Abstract][Full Text] [Related]
16. Analyses of MYC, ERBB2, and CCND1 genes in benign and malignant thyroid follicular cell tumors by real-time polymerase chain reaction.
Bièche I; Franc B; Vidaud D; Vidaud M; Lidereau R
Thyroid; 2001 Feb; 11(2):147-52. PubMed ID: 11288983
[TBL] [Abstract][Full Text] [Related]
17. Detection of activated ras oncogenes in human thyroid carcinomas.
Suárez HG; Du Villard JA; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R
Oncogene; 1988 Apr; 2(4):403-6. PubMed ID: 3283656
[TBL] [Abstract][Full Text] [Related]
18. No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan.
Liu RT; Chen YJ; Chou FF; Li CL; Wu WL; Tsai PC; Huang CC; Cheng JT
Clin Endocrinol (Oxf); 2005 Oct; 63(4):461-6. PubMed ID: 16181240
[TBL] [Abstract][Full Text] [Related]
19. Identification of rapid turnover transcripts overexpressed in thyroid tumors and thyroid cancer cell lines: use of a targeted differential RNA display method to select for mRNA subsets.
Gonsky R; Knauf JA; Elisei R; Wang JW; Su S; Fagin JA
Nucleic Acids Res; 1997 Oct; 25(19):3823-31. PubMed ID: 9380504
[TBL] [Abstract][Full Text] [Related]
20. High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma.
Bongarzone I; Pierotti MA; Monzini N; Mondellini P; Manenti G; Donghi R; Pilotti S; Grieco M; Santoro M; Fusco A
Oncogene; 1989 Dec; 4(12):1457-62. PubMed ID: 2594368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
